105 related articles for article (PubMed ID: 18047607)
1. Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro.
Bissett DL; Farmer T; McPhail S; Reichling T; Tiesman JP; Juhlin KD; Hurley GJ; Robinson MK
J Cosmet Dermatol; 2007 Dec; 6(4):232-8. PubMed ID: 18047607
[TBL] [Abstract][Full Text] [Related]
2. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial.
Kimball AB; Kaczvinsky JR; Li J; Robinson LR; Matts PJ; Berge CA; Miyamoto K; Bissett DL
Br J Dermatol; 2010 Feb; 162(2):435-41. PubMed ID: 19845667
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
[TBL] [Abstract][Full Text] [Related]
4. Understanding metabolic pathways for skin anti-aging.
Osborne R; Mullins LA; Jarrold BB
J Drugs Dermatol; 2009 Jul; 8(7 Suppl):s4-7. PubMed ID: 19623777
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
[TBL] [Abstract][Full Text] [Related]
6. The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches.
Gillbro JM; Olsson MJ
Int J Cosmet Sci; 2011 Jun; 33(3):210-21. PubMed ID: 21265866
[TBL] [Abstract][Full Text] [Related]
7. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine.
Bissett DL; Robinson LR; Raleigh PS; Miyamoto K; Hakozaki T; Li J; Kelm GR
J Cosmet Dermatol; 2007 Mar; 6(1):20-6. PubMed ID: 17348991
[TBL] [Abstract][Full Text] [Related]
8. Glucosamine: an ingredient with skin and other benefits.
Bissett DL
J Cosmet Dermatol; 2006 Dec; 5(4):309-15. PubMed ID: 17716251
[TBL] [Abstract][Full Text] [Related]
9. Topical methimazole as a new treatment for postinflammatory hyperpigmentation: report of the first case.
Kasraee B; Handjani F; Parhizgar A; Omrani GR; Fallahi MR; Amini M; Nikbakhsh M; Tran C; Hügin A; Sorg O; Saurat JH
Dermatology; 2005; 211(4):360-2. PubMed ID: 16286748
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and moisturizing effect of liposomes containing glucosamine and N-acetyl glucosamine.
Malaekeh-Nikouei B; Golmohammadzadeh S; Salmani-Chamanabad S; Mosallaei N; Jamialahmadi K
J Cosmet Dermatol; 2013 Jun; 12(2):96-102. PubMed ID: 23725302
[TBL] [Abstract][Full Text] [Related]
11. A Zn(II)-glycine complex suppresses UVB-induced melanin production by stimulating metallothionein expression.
Ochiai Y; Kaburagi S; Okano Y; Masaki H; Ichihashi M; Funasaka Y; Sakurai H
Int J Cosmet Sci; 2008 Apr; 30(2):105-12. PubMed ID: 18377619
[TBL] [Abstract][Full Text] [Related]
12. The effect of N-acetyl-glucosamine on stratum corneum desquamation and water content in human skin.
Mammone T; Gan D; Fthenakis C; Marenus K
J Cosmet Sci; 2009; 60(4):423-8. PubMed ID: 19691938
[TBL] [Abstract][Full Text] [Related]
13. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
14. A regulator of ubiquitin-proteasome activity, 2-hexyldecanol, suppresses melanin synthesis and the appearance of facial hyperpigmented spots.
Hakozaki T; Laughlin T; Zhao S; Wang J; Deng D; Jewell-Motz E; Elstun L
Br J Dermatol; 2013 Jul; 169 Suppl 2():39-44. PubMed ID: 23786619
[TBL] [Abstract][Full Text] [Related]
15. Deoxypodophyllotoxin reduces skin pigmentation of brown Guinea pigs.
Choi H; Lee J; Shin HJ; Lee BG; Chang I; Hwang JS
Planta Med; 2004 Apr; 70(4):378-80. PubMed ID: 15095159
[TBL] [Abstract][Full Text] [Related]
16. In vitro antioxidant activity and in vivo efficacy of topical formulations containing vitamin C and its derivatives studied by non-invasive methods.
Campos PM; Gonçalves GM; Gaspar LR
Skin Res Technol; 2008 Aug; 14(3):376-80. PubMed ID: 19159387
[TBL] [Abstract][Full Text] [Related]
17. A clinical study of topical Pyratine 6 for improving the appearance of photodamaged skin.
McCullough JL; Garcia RL; Reece B
J Drugs Dermatol; 2008 Feb; 7(2):131-5. PubMed ID: 18335649
[TBL] [Abstract][Full Text] [Related]
18. Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo.
Rittié L; Kang S; Voorhees JJ; Fisher GJ
Arch Dermatol; 2008 Sep; 144(9):1129-40. PubMed ID: 18794456
[TBL] [Abstract][Full Text] [Related]
19. Antimelanogenic activity of a novel adamantyl benzylbenzamide derivative, AP736: a randomized, double-blind, vehicle-controlled comparative clinical trial performed in patients with hyperpigmentation during the summer.
Jeong YS; Kim JH; Choi J; Baek HS; Joo YH; Lee CS; Shin HJ; Park YH; Kim BJ; Shin SS
Int J Dermatol; 2016 Jun; 55(6):e321-6. PubMed ID: 26712041
[TBL] [Abstract][Full Text] [Related]
20. Effects of a Brazilian herbal compound as a cosmetic eyecare for periorbital hyperchromia ("dark circles").
Eberlin S; Del Carmen Velazquez Pereda M; de Campos Dieamant G; Nogueira C; Werka RM; de Souza Queiroz ML
J Cosmet Dermatol; 2009 Jun; 8(2):127-35. PubMed ID: 19527337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
